ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2105

Genetic Analysis of a Drosophila Systemic Lupus Erythematosus Model Reveals Lupus Susceptibility Genes

Pooja KR, Brooklynne Thielen, Xavier Hernandez and Nathan Mortimer, School of Biological Sciences, Illinois State University, Normal, IL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: genetics and innate immunity, Janus kinase (JAK), SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder with various immunological abnormalities and a diverse range of clinical symptoms. In contrast to the traditional belief that SLE is solely an adaptive immune disorder, multiple studies of patient samples and mouse models have revealed the involvement of innate immune mechanisms in the initiation of SLE. However, the exact role of innate immunity in SLE pathogenesis is unknown, thus we have developed a new model to understand the genetic complexity of disease development and susceptibility. Drosophila is well suited to this research as the innate immune pathways are well conserved between humans and mammals including the JAK-STAT pathway which has been specifically implicated in pathology of SLE in humans. To understand the regulation of the JAK-STAT pathway and its role in SLE, we are utilizing our newly developed Drosophila SLE model, which has a gain of function mutation in the Drosophila homolog of JAK. Our goal is to identify genes that contribute to the SLE-like phenotype with a particular focus on JAK-STAT signaling.

Methods: To identify genes that modify the Drosophila SLE model phenotype, we performed two genetic screens. Forward genetic screening was performed in which 20% of the Drosophila genome was screened to look for regions containing genes involved in the autoimmune response in the Drosophila SLE model. To understand the role of JAK-STAT signaling in regulating autoimmunity, we conducted a reverse genetic screen in which we tested the role of candidate transcriptional factors in the SLE model autoimmune phenotype. We selected these genes based on previous links to JAK-STAT and then used RNAi to knockdown these genes in immune cells in our Drosophila model.

Results: We performed genetic screening and identified novel genes associated with SLE that may regulate conserved transcriptional networks which underlie self-tolerance. Our genetic modifier screen revealed 12 regions that modified the SLE phenotype. We predict that these regions contain genes that function in SLE-associated autoimmune mechanisms. Since our SLE mutant has a gain of function mutation in JAK-STAT, we conducted a reverse genetic screen that focused on understanding of the role of this pathway in autoimmunity. We discovered that RNAi mediated knockdown of candidate transcription factors in mutant immune cells suppressed the phenotype, suggesting that these genes promote JAK-STAT activity.

Conclusion: This study uncovers novel genetic interactions that may play a role in the contribution of the JAK-STAT pathway to SLE pathogenesis. The human homologs of two of our identified JAK-STAT interacting genes, AFF1 and BACH2, have been previously linked to SLE, whereas the others represent putative novel SLE risk factors. Identification of these new genes and genetic interactions will expand our knowledge of the processes which lead to autoimmune disorders, and investigating their molecular role in the Drosophila SLE model may well open a new window for the understanding and clinical treatment of this complex disease.


Disclosure: P. KR, None; B. Thielen, None; X. Hernandez, None; N. Mortimer, None.

To cite this abstract in AMA style:

KR P, Thielen B, Hernandez X, Mortimer N. Genetic Analysis of a Drosophila Systemic Lupus Erythematosus Model Reveals Lupus Susceptibility Genes [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/genetic-analysis-of-a-drosophila-systemic-lupus-erythematosus-model-reveals-lupus-susceptibility-genes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-analysis-of-a-drosophila-systemic-lupus-erythematosus-model-reveals-lupus-susceptibility-genes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology